Glenn Kulzer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 N Montana St, Dillon, MT 59725 Phone: 406-683-6226 |
Dr. Kea Lynn Greemore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 N Montana St, Dillon, MT 59725 Phone: 406-683-6226 Fax: 406-683-6253 |
Bonnie Rose Rebish Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 Southside Blvd, Dillon, MT 59725 Phone: 406-988-7121 Fax: 406-683-3540 |
Nicole Crawford, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 E Glendale St, Dillon, MT 59725 Phone: 406-683-2316 Fax: 406-683-5182 |
Lyndee L Fogel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 90 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-3211 |
Mrs. Jody I Bowman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 330 Rodeo Trl, Dillon, MT 59725 Phone: 406-683-6269 |
Matthew Bowman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-3102 Fax: 406-683-3118 |
Cassandra Raffety, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-3102 |
Kelly Adams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 E Glendale St, Dillon, MT 59725 Phone: 406-683-4440 |
Patricia Mitchell, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 E Glendale St, Dillon, MT 59725 Phone: 406-683-2316 |
Charles Lee Adams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 N Montana St, Dillon, MT 59725 Phone: 406-683-6226 |
News Archive
Research published in JAMA demonstrates strong evidence of a link between childhood obesity and bisphenol A exposure.
A team led by MIT neuroscientists has developed a way to monitor how brain cells coordinate with each other to control specific behaviors, such as initiating movement or detecting an odor.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO).
Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA.
› Verified 4 days ago